Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN FRANCISCO, June 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...
-
SAN FRANCISCO, June 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...
-
SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...
-
SAN FRANCISCO, June 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...